RecruitingNot applicableNCT07524829
Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients
Studying Toxic dermatosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Azienda Sanitaria Locale di Asti
- Principal Investigator
- MANUELA CANICATTI', RN, MSc, PhD(c)ASL AT
- Intervention
- Structured Telenursing Follow-up(behavioral)
- Enrollment
- 124 target
- Eligibility
- 18 years · FEMALE
- Timeline
- 2024 – 2028
Study locations (1)
- Cardinal Massaia Hospital - S.C. Oncology, Azienda Sanitaria Locale AT (ASL AT), Asti, ASTI, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07524829 on ClinicalTrials.govOther trials for Toxic dermatosis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07476807Telemedicine Rash Evaluation and Assessment of Toxicity in Skin in Acute Oncology and Haematology Care: A Pilot StudySligo General Hospital
- RECRUITINGPHASE3NCT06044623Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer PatientsRegion Örebro County
- RECRUITINGNANCT04650256Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural SciencesUniversity of Miami
- ACTIVE NOT RECRUITINGPHASE2NCT04879563Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE ProjectRegion Örebro County